Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics Post author:Sam Post published:December 3, 2017 Post category:BioPharma The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace You Might Also Like Gamida Cell Taps Former Clal Biotech CSO as New Leader November 19, 2017 Aeglea BioTherapeutics Updates Phase I/II Trial Data March 12, 2018 FDA Advisory Panel Votes Against Approval Of Johnson & Johnson???s Sirukumab August 2, 2017